Automatic blood grouping analyzer is an analyzer that can forward and reverse ABO blood group, Rh (D) blood group test, irregular antibody screening and cross-matching of blood test. It mainly consists of liquid handling system, incubator, centrifuge, interpretoscope, and microcomputer system.

Roche announced today its cobas Babesia blood test for individual blood donation testing has received marketing approval from the US Food and Drug Administration.

Thermo Fisher Scientific today priced an underwritten offering of a series of euro- and dollar-denominated senior notes, in an aggregate principal amount of $5.7 billion.

Diagnostics developer DiamiR said today that it has received an additional $345,000 in grant funding from the National Institute on Aging to develop a microRNA-based test for early-stage Alzheimer's disease.

The global immunoassay market is projected to grow at a CAGR of 5.9% from 2019 to reach USD 19.76 billion by 2025, driven by increasing incidences of chronic and infectious diseases

Bio-Rad Laboratories yesterday filed another lawsuit accusing 10x Genomics of patent infringement.

10x Genomics recently priced its initial public offering of 10 million shares of its common stock at $39 per share.

Sano Genetics has partnered with GenePlaza to link individuals who have used direct-to-consumer (DTC) genetic tests with clinical trials and other research programs, the companies said recently.

Horizon Discovery Group reported recently that its total revenues as reported for the first half of 2019 rose 14 percent, thanks to large increases in revenues from its bioproduction and screening business units.

Novigenix said recently that it has tapped Belgium-based startup bioinformatics firm BioLizard to develop an artificial intelligence-based algorithm to support the transition of its Colox immuno-transcriptomic RT-PCR product onto a new platf

Ginkgo Bioworks recently announced a $290M Series E financing round from new and prior investors.